The relevance of attributable risk measures to HIV prevention planning

AIDS

Volumn 17, Issue 6, 2003, Pages 911-913

  Hagan, Holly ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

AIDS; Cocaine; HIV; Injecting drug use

Indexed keywords

CANADA; FEMALE; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MALE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; UNITED STATES;

COCAINE-RELATED DISORDERS; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 0038301448     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200304110-00017     Document Type: Review

References (7)

1. Tyndal MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, Schechter MT. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003, 17:887-893.
2. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989, 261:561-565.
3. Hankins C, Alary M, Parent R, Blanchette C, Claessens C, The SurvUDI Working Group. Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000. J Acquir Immune Defic Syndr 2002, 30:514-521.
4. Cole P, MacMahon B. Attributable risk percent in case-control studies. Br J Prey Soc Med 1971, 25:242-244.
5. Kral A, Bluthenthal RN, Lorrick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk factor analysis. Lancet 2001, 357:1397-1401.
6. Rothman KJ. Modern Epidemiology. Boston: Little, Brown and Co.; 1986:38-39.
7. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little, Brown and Co.; 1987:87-93.